Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies

Metastatic events to the bone occur frequently in numerous cancer types such as breast, prostate, lung, and renal carcinomas, melanoma, neuroblastoma, and multiple myeloma. Accumulating evidence suggests that the inflammatory cytokine interleukin (IL)-6 is frequently upregulated and is implicated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawara, Ken, Oxford, Julia T, Jorcyk, Cheryl L
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101113/
https://www.ncbi.nlm.nih.gov/pubmed/21625400
http://dx.doi.org/10.2147/CMR.S18101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101113/
https://www.ncbi.nlm.nih.gov/pubmed/21625400
http://dx.doi.org/10.2147/CMR.S18101

Ejemplares similares